US2022202854A1PendingUtilityA1

Human facilitating cells

67
Assignee: UNIV LOUISVILLE RES FOUND INCPriority: May 30, 2008Filed: Mar 14, 2022Published: Jun 30, 2022
Est. expiryMay 30, 2028(~1.8 yrs left)· nominal 20-yr term from priority
Inventors:Suzanne T. IldstadMary Jane Elliott
C12N 2510/00C12N 2501/515C12N 2501/505C12N 2501/599A61K 40/50A61K 40/418A61K 40/40A61K 40/22A61K 40/11A61K 40/10A61K 2239/38C12N 5/0636C12N 5/0634A61K 35/28A61P 31/14C12N 5/0647A61P 7/06A61P 35/00A61P 31/18A61P 35/02C12N 5/0652A61P 1/16A61P 31/12A61P 37/02A61P 3/00A61P 3/10A61K 35/12A61P 25/28A61P 37/06A61P 7/00A61P 25/00A61P 37/00A61K 35/17
67
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present disclosure relates to human facilitating cells (hFC), and methods of isolating, characterizing, and using such hFCs.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A cellular composition comprising at least about 30% human facilitating cells (hFCs), wherein said hFCs comprise cells having a phenotype of CD8+/alpha beta TCR−/CD56 dim/neg  and cells having a phenotype of CD8+/alpha beta TCR−/CD56 bright .

Join the waitlist — get patent alerts

Track US2022202854A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.